Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleBasic Science Investigation

Imaging Lipid Synthesis in Hepatocellular Carcinoma with [Methyl-11C]Choline: Correlation with In Vivo Metabolic Studies

Yu Kuang, Nicolas Salem, Haibin Tian, Jeffrey A. Kolthammer, David J. Corn, Chunying Wu, Fangjing Wang, Yanming Wang and Zhenghong Lee
Journal of Nuclear Medicine January 2011, 52 (1) 98-106; DOI: https://doi.org/10.2967/jnumed.110.080366
Yu Kuang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicolas Salem
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Haibin Tian
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey A. Kolthammer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David J. Corn
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chunying Wu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fangjing Wang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yanming Wang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhenghong Lee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 52 no. 1 98-106
DOI 
https://doi.org/10.2967/jnumed.110.080366
PubMed 
21149484

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication June 18, 2010
  • Accepted for publication September 23, 2010
  • Published online December 28, 2010.

Article Versions

  • previous version (December 13, 2010 - 05:59).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2011 by Society of Nuclear Medicine

Author Information

  1. Yu Kuang*,1,
  2. Nicolas Salem*,1,
  3. Haibin Tian2,
  4. Jeffrey A. Kolthammer1,
  5. David J. Corn2,
  6. Chunying Wu2,
  7. Fangjing Wang1,
  8. Yanming Wang2 and
  9. Zhenghong Lee1,2
  1. 1Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio; and
  2. 2Nuclear Medicine Division, Department of Radiology, University Hospitals Case Medical Center, Cleveland, Ohio
  1. For correspondence or reprints contact: Zhenghong Lee, Nuclear Medicine Division, Department of Radiology, University Hospitals Case Medical Center, 11100 Euclid Ave., Cleveland, OH 44106. E-mail: zhenghong.lee{at}case.edu
View Full Text

Statistics from Altmetric.com

Cited By...

  • 26 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Diagnostic value of combining 11C-choline and 18F-FDG PET/CT in hepatocellular carcinoma
    Maria-Angéla Castilla-Lièvre, Dominique Franco, Philippe Gervais, Bertrand Kuhnast, Hélène Agostini, Lysiane Marthey, Serge Désarnaud, Badia-Ourkia Helal
    European Journal of Nuclear Medicine and Molecular Imaging 2016 43 5
  • Established and novel imaging biomarkers for assessing response to therapy in hepatocellular carcinoma
    Tao Jiang, Andrew X. Zhu, Dushyant V. Sahani
    Journal of Hepatology 2013 58 1
  • Diagnostic role of radiolabelled choline PET or PET/CT in hepatocellular carcinoma: a systematic review and meta-analysis
    Francesco Bertagna, Mattia Bertoli, Giovanni Bosio, Giorgio Biasiotto, Ramin Sadeghi, Raffaele Giubbini, Giorgio Treglia
    Hepatology International 2014 8 4
  • Diagnostic accuracy of 11C-choline PET/CT in comparison with CT and/or MRI in patients with hepatocellular carcinoma
    Egesta Lopci, Guido Torzilli, Dario Poretti, Lauro J. Souza de Neto, Matteo Donadon, Lorenza Rimassa, Ezio Lanza, Juliano Guerra Sabongi, Roberto Ceriani, Nicola Personeni, Angela Palmisano, Vittorio Pedicini, Tiziana Comito, Marta Scorsetti, Arturo Chiti
    European Journal of Nuclear Medicine and Molecular Imaging 2015 42 9
  • PET imaging of hepatocellular carcinoma with 18F-fluoroethylcholine and 11C-choline
    Jeffrey A. Kolthammer, David J. Corn, Nathan Tenley, Chunying Wu, Haibin Tian, Yanming Wang, Zhenghong Lee
    European Journal of Nuclear Medicine and Molecular Imaging 2011 38 7
  • Hepatocellular Carcinoma and Gastroenteropancreatic Neuroendocrine Tumors: Potential Role of Other Positron Emission Tomography Radiotracers
    Hossein Jadvar
    Seminars in Nuclear Medicine 2012 42 4
  • Use of choline PET for studying hepatocellular carcinoma
    Jean-Noël Talbot, Laure Michaud, Jean-Didier Grange, Olivier Rosmorduc, Sona Balogova
    Clinical and Translational Imaging 2014 2 2
  • [18F]Fluorocholine PET/CT Imaging of Liver Cancer: Radiopathologic Correlation with Tissue Phospholipid Profiling
    Sandi A. Kwee, Miles M. Sato, Yu Kuang, Adrian Franke, Laurie Custer, Kyle Miyazaki, Linda L. Wong
    Molecular Imaging and Biology 2017 19 3
  • Transarterial Chemoembolization in a Woodchuck Model of Hepatocellular Carcinoma
    William F. Pritchard, David L. Woods, Juan A. Esparza-Trujillo, Matthew F. Starost, Michal Mauda-Havakuk, Andrew S. Mikhail, Ivane Bakhutashvili, Shelby Leonard, Elizabeth C. Jones, Venkatesh Krishnasamy, John W. Karanian, Bradford J. Wood
    Journal of Vascular and Interventional Radiology 2020 31 5
  • Functional imaging techniques in hepatocellular carcinoma
    V. Goh, D. Sarker, S. Osmany, G. J. R. Cook
    European Journal of Nuclear Medicine and Molecular Imaging 2012 39 6

Article usage

Article usage: December 2010 to November 2023

AbstractFullPdf
Dec 201098434
Jan 2011813148
Feb 2011292535
Mar 201150712
Apr 201134811
May 201121912
Jun 2011921313
Jul 2011443216
Aug 2011672030
Sep 2011562328
Oct 2011543528
Nov 2011532238
Dec 2011571524
Jan 2012411525
Feb 2012521522
Mar 2012541726
Apr 2012382527
May 2012382519
Jun 2012301214
Jul 2012202625
Aug 201228721
Sep 2012331229
Oct 2012271520
Nov 2012381327
Dec 201225719
Jan 201327921
Feb 2013271823
Mar 201321817
Apr 2013251826
May 2013211222
Jun 201310119
Jul 201315715
Aug 201313919
Sep 201317521
Oct 2013151123
Nov 201351012
Dec 2013141322
Jan 201412714
Feb 2014111431
Mar 2014111343
Apr 201411725
May 201411516
Jun 201413513
Jul 201410616
Aug 20141488
Sep 2014141821
Oct 2014272119
Nov 201412613
Dec 201412810
Jan 20151499
Feb 2015161510
Mar 2015201818
Apr 20155910
May 2015151917
Jun 201520179
Jul 20158417
Aug 201514119
Sep 2015121011
Oct 20151109
Nov 201513137
Dec 201538129
Jan 2016281521
Feb 2016141115
Mar 201691520
Apr 20168212
May 201611109
Jun 201681414
Jul 2016191513
Aug 2016151112
Sep 20161498
Oct 2016181131
Nov 20161388
Dec 201611118
Jan 2017211428
Feb 2017111512
Mar 201712148
Apr 201710127
May 20176159
Jun 201781510
Jul 20176176
Aug 201791910
Sep 201771512
Oct 201781110
Nov 201714128
Dec 201711173
Jan 2018172225
Feb 20187244
Mar 201882912
Apr 201812234
May 20188261
Jun 20188236
Jul 20183202
Aug 201811207
Sep 201853012
Oct 201863413
Nov 201810349
Dec 20189393
Jan 201910326
Feb 20194204
Mar 201914263
Apr 20199257
May 201982613
Jun 201929174
Jul 201911237
Aug 201912232
Sep 20196104
Oct 201913148
Nov 20199127
Dec 20198114
Jan 202011112
Feb 20208105
Mar 2020894
Apr 2020684
May 20208169
Jun 20206127
Jul 20209153
Aug 20209104
Sep 2020864
Oct 20201757
Nov 20209108
Dec 202015157
Jan 202131812
Feb 202141819
Mar 202141810
Apr 20214133
May 202143212
Jun 20217156
Jul 202122115
Aug 20211181
Sep 202111913
Oct 202181920
Nov 202132418
Dec 20213298
Jan 202272314
Feb 20225206
Mar 202263312
Apr 20221226
May 202243117
Jun 202241810
Jul 20221265
Aug 20227499
Sep 202241413
Oct 20223196
Nov 20224176
Dec 20221244
Jan 202342213
Feb 20233144
Mar 20232137
Apr 20232155
May 20233137
Jun 20230111
Jul 202351312
Aug 20231107
Sep 20233106
Oct 202331611
Nov 20230144
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 52 (1)
Journal of Nuclear Medicine
Vol. 52, Issue 1
January 1, 2011
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Imaging Lipid Synthesis in Hepatocellular Carcinoma with [Methyl-11C]Choline: Correlation with In Vivo Metabolic Studies
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Imaging Lipid Synthesis in Hepatocellular Carcinoma with [Methyl-11C]Choline: Correlation with In Vivo Metabolic Studies
Yu Kuang, Nicolas Salem, Haibin Tian, Jeffrey A. Kolthammer, David J. Corn, Chunying Wu, Fangjing Wang, Yanming Wang, Zhenghong Lee
Journal of Nuclear Medicine Jan 2011, 52 (1) 98-106; DOI: 10.2967/jnumed.110.080366

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Imaging Lipid Synthesis in Hepatocellular Carcinoma with [Methyl-11C]Choline: Correlation with In Vivo Metabolic Studies
Yu Kuang, Nicolas Salem, Haibin Tian, Jeffrey A. Kolthammer, David J. Corn, Chunying Wu, Fangjing Wang, Yanming Wang, Zhenghong Lee
Journal of Nuclear Medicine Jan 2011, 52 (1) 98-106; DOI: 10.2967/jnumed.110.080366
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Transcriptomics Associates Molecular Features with 18F-Fluorocholine PET/CT Imaging Phenotype and Its Potential Relationship to Survival in Hepatocellular Carcinoma
  • Google Scholar

More in this TOC Section

  • Performance Characteristics of a New-Generation Digital Bismuth Germanium Oxide PET/CT System, Omni Legend 32, According to NEMA NU 2-2018 Standards
  • Tumor-Targeted Interleukin 2 Boosts the Anticancer Activity of FAP-Directed Radioligand Therapeutics
  • Immuno-PET and Targeted α-Therapy Using Anti–Glypican-1 Antibody Labeled with 89Zr or 211At: A Theranostic Approach for Pancreatic Ductal Adenocarcinoma
Show more Basic Science Investigation

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire